GSIT vs INTT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GSIT presents a paradoxical financial profile: an exceptionally strong balance sheet paired with severe operational inefficiency. While the Piotroski F-Score of 4/9 indicates stable health and the current ratio of 10.42 shows massive liquidity, the company suffers from a -113.66% operating margin and a high Price/Sales ratio of 8.21. The combination of heavy insider selling by the CEO and officers, alongside a recent 34.9% monthly price collapse, suggests a lack of confidence in near-term profitability. Despite modest revenue growth, the lack of a positive Graham Number or intrinsic value baseline makes the current valuation speculative.
INTT exhibits a severe divergence between its market price and fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock has seen a massive 167.8% price increase over the last year, this rally is unsupported by deteriorating fundamentals, including negative YoY revenue growth (-10.30%) and negative earnings growth (-19.70%). The company is currently unprofitable with a negative ROE and profit margin, and insider activity is bearish with the CEO selling shares. The current valuation appears speculative and disconnected from the company's operational decline.
Compare Another Pair
Related Comparisons
GSIT vs INTT: Head-to-Head Comparison
This page compares GSI Technology, Inc. (GSIT) and InTest Corporation (INTT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.